XELOX Clinical Trials
12 recruitingDrug
Phase 28Phase 33Phase 12
Showing 1–12 of 12 trials
Recruiting
Phase 3
Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
Gastric CancerMetastatic CancerAdvanced Cancer+1 more
Centre Leon Berard132 enrolled6 locationsNCT06346197
Recruiting
Phase 1
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University9 enrolled2 locationsNCT06848465
Recruiting
Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
AstraZeneca163 enrolled44 locationsNCT05702229
Recruiting
Phase 2
CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
Colon Cancer
West China Hospital60 enrolled9 locationsNCT06242418
Recruiting
Phase 1Phase 2
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
Metastatic HER2 Positive Gastroesophageal Junction Cancer
Zhejiang Cancer Hospital90 enrolled1 locationNCT06650332
Recruiting
Phase 2
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Adebrelimab (SHR-1316)XELOXGC/GEJC
Tianjin Medical University Cancer Institute and Hospital25 enrolled1 locationNCT06506292
Recruiting
Phase 2
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Harbin Medical University50 enrolled1 locationNCT06196697
Recruiting
Phase 2
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
HER2-positive Locally Advanced Resectable Gastric Cancer
Peking University18 enrolled1 locationNCT06023758
Recruiting
Phase 2
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Advanced Rectal Cancer
Zhen-Hai Lu121 enrolled1 locationNCT05228431
Recruiting
Phase 2
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Gastric CancerGastroesophageal-junction CancerCarcinoma+4 more
The First Affiliated Hospital with Nanjing Medical University80 enrolled1 locationNCT05494060
Recruiting
Phase 3
Perioperative FLOT vs Adjuvant XELOX for CA Stomach
Cancer of Stomach, Adenocarcinoma
Chinese University of Hong Kong110 enrolled1 locationNCT05264896
Recruiting
Phase 3
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Rectal Cancer
Sun Yat-sen University776 enrolled2 locationsNCT03671252